Martín, M.A., Lucia, A., Arenas, J. & Andreu, A.L. Glycogen storage disease type V. In (eds Adam. M.P., et al.) GeneReviews® [Internet]: University of Washington (Seattle (WA), 1993).
Vieitez, I. et al. Molecular and clinical study of McArdle’s disease in a cohort of 123 European patients. Identification of 20 novel mutations. Neuromuscul. Disord. 21, 817–823 (2011).
Lucia, A. et al. Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J. Neurol. Neurosurg. Psychiatry 83, 322–328 (2012).
Lucia, A., Martinuzzi, A., Nogales-Gadea, G., Quinlivan, R. & Reason, S. Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group. Neuromuscul. Disord. 31, 1296–1310 (2021).
Milstein, J. M., Herron, T. M. & Haas, J. E. Fatal infantile muscle phosphorylase deficiency. J. Child Neurol. 4, 186–188 (1989).
Article PubMed CAS Google Scholar
Bartram, C., Edwards, R. H., Clague, J. & Beynon, R. J. McArdle’s disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases. Hum. Mol. Genet 2, 1291–1293 (1993).
Article PubMed CAS Google Scholar
Nogales-Gadea, G. et al. Exercise and preexercise nutrition as treatment for McArdle disease. Med. Sci. Sports Exerc. 48, 673–679 (2016).
Bollig, G. Sports and McArdle disease (glycogen storage disease type V): danger or therapy? [Internet]. In (eds Khan, J. & Hsieh, P.-S.) Ch 10 (Rijeka, IntechOpen). https://doi.org/10.5772/intechopen.89204 (2019).
Bollig, G. McArdle’s disease (glycogen storage disease type V) and anesthesia—a case report and review of the literature. Paediatr. Anaesth. 23, 817–823 (2013).
Vladutiu, G. D. Genetic predisposition to statin myopathy. Curr. Opin. Rheumatol. 20, 648–655 (2008).
Article PubMed CAS Google Scholar
Martín, M. A. et al. Molecular heterogeneity of myophosphorylase deficiency (McArdle’s disease): a genotype-phenotype correlation study. Ann. Neurol. 50, 574–581 (2001).
Martinuzzi, A. et al. Phenotype modulators in myophosphorylase deficiency. Ann. Neurol. 53, 497–502 (2003).
Article PubMed CAS Google Scholar
Bruno, C. et al. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort. Hum. Mutat. 27, 718 (2006).
Quinlivan, R. et al. McArdle disease: a clinical review. J. Neurol. Neurosurg. Psychiatry 81, 1182–1188 (2010).
Article PubMed CAS Google Scholar
Santalla, A. et al. Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update. BMC Genomics 18, 819 (2017).
Article PubMed PubMed Central Google Scholar
Nogales-Gadea, G. et al. Next-generation sequencing to estimate the prevalence of a great unknown: McArdle disease. Genet Med. 17, 679–680 (2015).
Article PubMed CAS Google Scholar
Scalco, R. S. et al. Misdiagnosis is an important factor for diagnostic delay in McArdle disease. Neuromuscul. Disord. 27, 852–855 (2017).
Maté-Munoz, J. L. et al. Favorable responses to acute and chronic exercise in McArdle patients. Clin. J. Sport Med. 17, 297–303 (2007).
Rommel, O. et al. Muscle pain in myophosphorylase deficiency (McArdle’s disease): the role of gender, genotype, and pain-related coping. Pain 124, 295–304 (2006).
Article PubMed CAS Google Scholar
Gariani, K., Nascimento, M., Superti-Furga, A. & Tran, C. Clouds over IMD? Perspectives for inherited metabolic diseases in adults from a retrospective cohort study in two Swiss adult metabolic clinics. Orphanet J. Rare Dis. 15, 210 (2020).
Article PubMed PubMed Central Google Scholar
Duno, M., Quinlivan, R., Vissing, J. & Schwartz, M. High‐resolution melting facilitates mutation screening of PYGM in patients with McArdle disease. Ann. Hum. Genet 73, 292–297 (2009).
Article PubMed CAS Google Scholar
Nogales-Gadea, G. et al. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Brain 135, 2048–2057 (2012).
Comments (0)